Product
Capsaicin patch
1 clinical trial
1 indication
Indication
Head and Neck CancerClinical trial
Phase II Randomized Controlled Study Aiming to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain.Status: Recruiting, Estimated PCD: 2026-01-01